In 2022, ASCO launched living clinical practice guidelines for systemic therapy for patients with stage IV non–small cell lung cancer (NSCLC) with 1 and without 2 driver alterations. Both have been ...

Liability Risks of Ambient Clinical Workflows With Artificial Intelligence for Clinicians, Hospitals, and Manufacturers ...

To advance the call to action to optimize dosage of anticancer agents, FDA and ASCO cosponsored two multistakeholder workshops, Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology ...

Authors' Disclosures of Potential Conflicts of Interest Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury ...

Early-phase clinical trials (EPCTs) have been increasingly adopted as the pivotal trial to support US Food and Drug Administration (FDA) approval of novel anticancer drugs. Among EPCT designs, ...

Upper tract urothelial carcinoma (UTUC) is one of the common urothelial cancers. Although large cohorts have illustrated spectrum of germline mutations, landscape of somatic alterations has not been ...

Low-dose radiation demonstrates efficacy in treating primary cutaneous T-cell lymphomas. This study evaluated the safety and efficacy of low-dose total skin electron beam therapy (TSEBT) regimens in ...

Artful Oncology is an innovative, multimodal, longitudinal curriculum for H/O fellows consisting of four pillars: (1) monthly psychosocial oncology didactics; (2) bimonthly narrative medicine seminars ...

The ability of large language models (LLMs) to identify access to germline genetic testing from unstructured text remains unknown. The Department of Veterans Affairs (VA) assessed access in Veterans ...

Systematic mediastinal lymph node dissection (LND) or sampling is currently recommended for patients with early-stage non–small cell lung cancer. We aimed to investigate whether no mediastinal LND was ...

In the article that accompanies this editorial, Yin et al 12 present the early phase development and validation of a fragmentomics-based biomarker for the earlier detection of pancreatic cancer. While ...

As global cancer rates rise, the demand for effective, high-quality delivery of systemic anticancer therapy (SACT) is crucial. However, quality improvement (QI) research in medical oncology remains ...